Highlight

RESEARCH 2007, August 29   Irfaq, a manufacturer of innovations     A true provider of outsourced research and development, Irfaq places its seasoned engineers at companies’ disposal. Wishing to meet a confidentiality requirement expressed by its customers, the laboratory has just moved into its new quarters in the Biopole buildings of the Patis zone. Metal-covered door, biometrically imprinted lock, secured wired intranet network... Irfaq recently moved and its CEO, Pierre Goffinet, availed himself of the opportunity to update his security system, It bears mentioning that the customers of this new-styled R & D center include the French army and several large-scale groups belonging to the luxury industry, Irfaq left Saint-Benoit for the buildings of the Biopole on the Patis site, quite close to the university hospital. “Prior to that, our laboratories were located on the same premises as those of the company named Quadripack. And even though we had no contact with them, our customers demanded heightened confidentiality”, explains the CEO, who created the structure in 1998. One customer, one formula More than a mere laboratory, Irfaq is a true outsourced R & D service provider that intervenes from experimentation tasks up until manufacture of a prototype. Wishing to render its approach signally credible, Irfaq guarantees each of its customers an original idea. Here, in a nutshell, is Pierre Goffinet’s explanation: “A chemical formula that we elaborate for a customer cannot be proposed to another firm. Moreover, if we do not produce anything, it is so as not to become a competitor ourselves.” It is by no means a rare occurrence that above and beyond its ongoing technological and biological watch, Irfaq draws up patent claims in the name of its prime manufacturers. Seven full-time engineers are currently employed by this sub-contracting laboratory, which hopes to recruit five more over the next three years. Irfaq should achieve 2007 sales of 1.1 million euros, and that would nearly double the corresponding figure for 2006. “Export, and the Italian market in particular, are tracks worth pursuing”, so states the CEO. Aside from cosmetics, bacteriological decontamination in the hospital and veterinary fields should stand to propel the development of Irfaq. On this score, today’s multiplication of nosocomial diseases, as well as seasonal outbreaks of bird flu, are singularly persuasive examples of how far this firm now has yet to go. http://www.irfaq.com The Biopole en masse at Eurobio 2008 Read ...   Water information days (September 23 – September 25) Read ...   The rose and its genetic transformation Read ...   Christian Huyghe aims for “excellence” read...   Creating “medical branches” read...   A neuro-cardio-vascular pole is taking root read...   Valagro on the horticulture market read...   ERM, the winning spin-off read...   GMOs under debate in Poitiers read...   Isabelle Cameleyre, new representative read...   Cystic fibrosis: The molecule of hope read...   Irfaq, a manufacturer of innovations read...   CHU: State-of-the-art quality read...   Soil organic matter under examination read...   Parexel: The Cap provides its support read...   Philippe Michonneau: “The Biopole, fertile soil” read...   Painless monitoring of hepatitis read...   The Biopole structured as an association read...   Futuramat steps up the pace read...   Technova, or life in 3D read...   B Braun burnishes its image read...   Proteomics platform: The CHU strides ahead read...   The three missions of the University Botanical Garden read...   Clinsight in the big leagues read...   Natural energies for an autonomous building read...   Aster-Cephac turns into SGS Cephac read...   The previously unseen heart read...   BIOalternatives diversifies its markets read...   Two Poitiers-based projects awarded read...   IUT pores over biofuels read...   Poitiers, the biotechnology capital read...   PAREXEL wagers on the human factor read...   Saunier and associates wish to diversify read...   Biocydex and BioXtract move forward hand in hand read...   The grass of champions read...   Ianesco steadfastly believes in its future read...   A tumorotheque, what is the purpose it serves? read...   TechnAvOx has turned the corner read...   Larime is aiming for 40 beds in Poitiers read...   Poitiers is out to promote its research read...   A true Biopole milestone read...   A regional cancerology pole in the pipeline for 2007 read...   Nobel prize winners in Poitiers read...   A platform offering numerous advantages read...   @rtMolecule fashions in its own way read...   It’s plastic, it’s fantastic read...   The Poitiers hospital (CHU) stakes its claim read...   BIOalternatives exports its know-how read...   The physiological and computer science engineering program turns 30 read...   The Biopole takes center stage at Investiga read...           Legal mentions